Ovarian Cancer Test Sales Are Illegal, FDA Warns

The Food and Drug Administration warned clinical test giant Laboratory Corp. of America Holdings that it was marketing an ovarian cancer test in violation of the law, vindicating skeptics of the assay who worried it wasn't ready for prime time.

OvaSure, developed by researchers at Yale School of Medicine, measures six proteins in blood samples and calculates the chances that the woman has ovarian cancer.

LabCorp, as the Burlington N.C., ... Full Story »

Posted by Kristin Gorski
Tags Help
Subjects: U.S., Politics, Health
Topics: Health Care, Cancer
Member Tags: Food and Drug Administration (FDA)
Editorial Help
Posted by: Posted by Kristin Gorski - Oct 8, 2008 - 11:34 PM PDT
Reviewed by: Kristin Gorski (review)
Edit Lock: This story can be edited
Edited by: Fabrice Florin - Oct 9, 2008 - 12:47 PM PDT

Reviews

Show All | Notes | Comments | Quotes | Links
Kristin Gorski
3.8
by Kristin Gorski - Oct. 8, 2008

Relevant piece -- is the FDA becoming much more wary in its approval process and also more responsive to medical and consumer critics? I don't know much about this field, but reporting on an FDA warning to stop test sales because they are "illegal" sounds newsworthy. The reporter gets key quotations from experts and stakeholders. What's missing is the consumer's point of view.

See Full Review » (20 answers)

Comments on this story Help (BETA)

NT Rating | My Rating

Ratings

3.7

not enough reviews
from 1 review (10% confidence)
Quality
3.7
Facts
4.0
Fairness
4.0
Information
4.0
Insight
4.0
Sourcing
3.0
Style
4.0
Accuracy
4.0
Balance
4.0
Context
4.0
Depth
3.0
Enterprise
3.0
Expertise
3.0
Originality
3.0
Relevance
4.0
Transparency
3.0
Responsibility
4.0
Popularity
3.9
Recommendation
4.0
Credibility
4.0
# Reviews
1.0
# Views
5.0
# Likes
1.0
# Emails
1.0
More
How our ratings work »
(See these related stories.)

Links Help

No links yet. Please review this story to add some!